SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-197833
Filing Date
2006-09-27
Accepted
2006-09-27 12:37:18
Documents
10
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d20f.htm 20-F 2001733
2 ARTICLES OF INCORPORATION dex11.htm EX-1.1 39566
3 REGULATIONS OF THE BOARD OF DIRECTORS dex12.htm EX-1.2 50691
4 REGULATIONS OF THE BOARD OF CORPORATE AUDITORS dex13.htm EX-1.3 35531
5 SHARE HANDLING REGULATIONS dex21.htm EX-2.1 75111
6 CODE OF ETHICS dex111.htm EX-11.1 10851
7 CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex121.htm EX-12.1 16418
8 CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT dex131.htm EX-13.1 4691
9 CONSENT OF ERNST & YOUNG SHINNIHON dex151.htm EX-15.1 1471
10 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex152.htm EX-15.2 3475
  Complete submission text file 0001193125-06-197833.txt   2240989
Mailing Address 5-1, NIHONBASHI 3-CHOME CHUO-KU, TOKYO M0 103-8426
Business Address 5-1, NIHONBASHI 3-CHOME CHUO-KU, TOKYO M0 103-8426 (011) 81-3-5255-7041
Daiichi Sankyo Company, LTD (Filer) CIK: 0001340156 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 333-128825 | Film No.: 061110568
SIC: 2834 Pharmaceutical Preparations